Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
22 Aug 2025 Job Information Organisation/Company Copenhagen Business School Department Department of Strategy and Innovation Research Field Economics Researcher Profile Recognised Researcher (R2
-
) interactions of natural materials and the effect of organic compounds on them. The team will merge data from traditional techniques with results from state-of-the-art, ultrahigh resolution instruments and
-
to: Collect data through e.g. literature studies regarding the raw materials to be used Perform data analysis and interpret results from chemical and microbial analysis of the raw materials Carry out product
-
or pedagogical qualifications. Reference letters and/or contact information for references. Link to GitHub. Any other documentation highlighting relevant qualifications for the position. UPLOAD GUIDE: Motivated
-
tissues and explore potential links with genetics and macromorphological characteristics. To this end, we will employ collection and analysis of tomographic data using state of the art synchrotron 3D
-
: Background in Data Science, Computer Science or related fields; Working experience in implementing AI models (not just loading pre-trained model). PyTorch framework is preferred; Experience with APIs
-
employment is 1 year. Starting date is 01.10.2025 (or according to mutual agreement). The position is a full-time position. You can read more about career paths at DTU here . Further information Further
-
candidate with strong methodological skills within coastal experimental laboratory work. You need to be able to work independently in the lab and take decisions on experimental setup and data treatment in
-
, and bioinformatics to make informed decisions on data analysis and validation experiments. Dr Francavilla’s team is funded by the Novo Nordisk Foundation and LEO Foundation and focuses on regulatory
-
, proteomics, and bioinformatics to make informed decisions on data analysis and validation experiments. Dr Francavilla’s team is funded by the Novo Nordisk Foundation and LEO Foundation and focuses